Celgene

Summit, New Jersey, United States ·Founded 1986

Overview

Celgene Corporation is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. \\Our talent, scientific knowledge and research capabilities help us to deliver access to innovative, disease-altering therapies to those who need them most. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.\\Celgene is headquartered in Summit, New Jersey, and employs more than 7,000 people located in more than 60 countries.\\For more information, please visit the Company's website at www.celgene.com.\\Before joining the discussion, please read Celgene's community guidelines on LinkedIn: http://bit.ly/298yijs

Get the full list of 54,000+ investors

Celgene and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Celgene

Who are the partners at Celgene?

Team members listed for Celgene include Jennifer Schutzman (Lead Medical Director) and Ken Caldera (Director HR).

How do I contact Celgene?

Celgene's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database